Mark Zuckerberg backed Cellular Intelligence has acquired Novo Nordisk’s Parkinson’s cell therapy after the Danish drugmaker shut down its cell therapy unit last October. Novo Nordisk said the restructuring meant discontinuing development of the therapy. The deal signals renewed interest in the approach and could reshape the therapy’s next development and commercialization plans.
IIT Madras scientists are using indigenous proprietary technology to create extremely high-resolution brain images by slicing tissue down to a fraction of a human hair. The resulting image bank is reported to be several times sharper than advanced MRI, offering new clues about how Alzheimer’s and Parkinson’s begin and progress—potentially accelerating earlier detection and better treatments.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
